世界の膣用リン酸クリンダマイシン市場 2019年

QYResearchが発行した調査報告書(QYR20FB04609)
◆英語タイトル:Global Clindamycin phosphate for Vaginal Market Professional Survey Report 2019
◆商品コード:QYR20FB04609
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年10月30日(※2024年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、膣用リン酸クリンダマイシンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、膣坐剤、膣クリームに、用途別には、病院、ドラッグストアにセグメント区分し、膣用リン酸クリンダマイシンの世界市場を分析しました。


・エグゼクティブ・サマリー
・膣用リン酸クリンダマイシンの世界市場概要
・膣用リン酸クリンダマイシンの製造コスト構成分析
・膣用リン酸クリンダマイシンの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・膣用リン酸クリンダマイシンの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・膣用リン酸クリンダマイシンのセグメント分析(種類別)
(膣坐剤、膣クリーム)
・膣用リン酸クリンダマイシンのセグメント分析(用途別)
(病院、ドラッグストア)
・膣用リン酸クリンダマイシンの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Pfizer、Perrigo)
・膣用リン酸クリンダマイシンの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Clindamycin phosphate for Vaginal is used for the treatment of non-pregnant women ≥ 18 years of age with bacterial vaginosis.
The global Clindamycin phosphate for Vaginal market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Clindamycin phosphate for Vaginal volume and value at global level, regional level and company level. From a global perspective, this report represents overall Clindamycin phosphate for Vaginal market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Clindamycin phosphate for Vaginal in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Clindamycin phosphate for Vaginal manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Perrigo

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Vaginal Suppositories
Vaginal cream

Segment by Application
Hospital
Drug Store

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Clindamycin phosphate for Vaginal
1.1 Definition of Clindamycin phosphate for Vaginal
1.2 Clindamycin phosphate for Vaginal Segment by Type
1.2.1 Global Clindamycin phosphate for Vaginal Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Vaginal Suppositories
1.2.3 Vaginal cream
1.3 Clindamycin phosphate for Vaginal Segment by Applications
1.3.1 Global Clindamycin phosphate for Vaginal Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Clindamycin phosphate for Vaginal Overall Market
1.4.1 Global Clindamycin phosphate for Vaginal Revenue (2014-2025)
1.4.2 Global Clindamycin phosphate for Vaginal Production (2014-2025)
1.4.3 North America Clindamycin phosphate for Vaginal Status and Prospect (2014-2025)
1.4.4 Europe Clindamycin phosphate for Vaginal Status and Prospect (2014-2025)
1.4.5 China Clindamycin phosphate for Vaginal Status and Prospect (2014-2025)
1.4.6 Japan Clindamycin phosphate for Vaginal Status and Prospect (2014-2025)
1.4.7 Southeast Asia Clindamycin phosphate for Vaginal Status and Prospect (2014-2025)
1.4.8 India Clindamycin phosphate for Vaginal Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Clindamycin phosphate for Vaginal
2.3 Manufacturing Process Analysis of Clindamycin phosphate for Vaginal
2.4 Industry Chain Structure of Clindamycin phosphate for Vaginal

3 Development and Manufacturing Plants Analysis of Clindamycin phosphate for Vaginal
3.1 Capacity and Commercial Production Date
3.2 Global Clindamycin phosphate for Vaginal Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Clindamycin phosphate for Vaginal
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Clindamycin phosphate for Vaginal Production and Capacity Analysis
4.2 Clindamycin phosphate for Vaginal Revenue Analysis
4.3 Clindamycin phosphate for Vaginal Price Analysis
4.4 Market Concentration Degree

5 Clindamycin phosphate for Vaginal Regional Market Analysis
5.1 Clindamycin phosphate for Vaginal Production by Regions
5.1.1 Global Clindamycin phosphate for Vaginal Production by Regions
5.1.2 Global Clindamycin phosphate for Vaginal Revenue by Regions
5.2 Clindamycin phosphate for Vaginal Consumption by Regions
5.3 North America Clindamycin phosphate for Vaginal Market Analysis
5.3.1 North America Clindamycin phosphate for Vaginal Production
5.3.2 North America Clindamycin phosphate for Vaginal Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Clindamycin phosphate for Vaginal Import and Export
5.4 Europe Clindamycin phosphate for Vaginal Market Analysis
5.4.1 Europe Clindamycin phosphate for Vaginal Production
5.4.2 Europe Clindamycin phosphate for Vaginal Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Clindamycin phosphate for Vaginal Import and Export
5.5 China Clindamycin phosphate for Vaginal Market Analysis
5.5.1 China Clindamycin phosphate for Vaginal Production
5.5.2 China Clindamycin phosphate for Vaginal Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Clindamycin phosphate for Vaginal Import and Export
5.6 Japan Clindamycin phosphate for Vaginal Market Analysis
5.6.1 Japan Clindamycin phosphate for Vaginal Production
5.6.2 Japan Clindamycin phosphate for Vaginal Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Clindamycin phosphate for Vaginal Import and Export
5.7 Southeast Asia Clindamycin phosphate for Vaginal Market Analysis
5.7.1 Southeast Asia Clindamycin phosphate for Vaginal Production
5.7.2 Southeast Asia Clindamycin phosphate for Vaginal Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Clindamycin phosphate for Vaginal Import and Export
5.8 India Clindamycin phosphate for Vaginal Market Analysis
5.8.1 India Clindamycin phosphate for Vaginal Production
5.8.2 India Clindamycin phosphate for Vaginal Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Clindamycin phosphate for Vaginal Import and Export

6 Clindamycin phosphate for Vaginal Segment Market Analysis (by Type)
6.1 Global Clindamycin phosphate for Vaginal Production by Type
6.2 Global Clindamycin phosphate for Vaginal Revenue by Type
6.3 Clindamycin phosphate for Vaginal Price by Type

7 Clindamycin phosphate for Vaginal Segment Market Analysis (by Application)
7.1 Global Clindamycin phosphate for Vaginal Consumption by Application
7.2 Global Clindamycin phosphate for Vaginal Consumption Market Share by Application (2014-2019)

8 Clindamycin phosphate for Vaginal Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Clindamycin phosphate for Vaginal Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Clindamycin phosphate for Vaginal Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Perrigo
8.2.1 Perrigo Clindamycin phosphate for Vaginal Production Sites and Area Served
8.2.2 Perrigo Product Introduction, Application and Specification
8.2.3 Perrigo Clindamycin phosphate for Vaginal Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served

9 Development Trend of Analysis of Clindamycin phosphate for Vaginal Market
9.1 Global Clindamycin phosphate for Vaginal Market Trend Analysis
9.1.1 Global Clindamycin phosphate for Vaginal Market Size (Volume and Value) Forecast 2019-2025
9.2 Clindamycin phosphate for Vaginal Regional Market Trend
9.2.1 North America Clindamycin phosphate for Vaginal Forecast 2019-2025
9.2.2 Europe Clindamycin phosphate for Vaginal Forecast 2019-2025
9.2.3 China Clindamycin phosphate for Vaginal Forecast 2019-2025
9.2.4 Japan Clindamycin phosphate for Vaginal Forecast 2019-2025
9.2.5 Southeast Asia Clindamycin phosphate for Vaginal Forecast 2019-2025
9.2.6 India Clindamycin phosphate for Vaginal Forecast 2019-2025
9.3 Clindamycin phosphate for Vaginal Market Trend (Product Type)
9.4 Clindamycin phosphate for Vaginal Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Clindamycin phosphate for Vaginal Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

...

【掲載企業】

Pfizer、Perrigo

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の膣用リン酸クリンダマイシン市場 2019年(Global Clindamycin phosphate for Vaginal Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。